Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SVREW vs GKOS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SVREW
SaverOne 2014 Ltd

Hardware, Equipment & Parts

TechnologyNASDAQ • IL
Market Cap
5Y Perf.-96.7%
GKOS
Glaukos Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$7.85B
5Y Perf.+195.4%

SVREW vs GKOS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SVREW logoSVREW
GKOS logoGKOS
IndustryHardware, Equipment & PartsMedical - Devices
Market Cap$7.85B
Revenue (TTM)$1M$551M
Net Income (TTM)$-23M$-189M
Gross Margin4.3%78.1%
Operating Margin-18.8%-15.6%
Total Debt$7M$140M
Cash & Equiv.$13M$91M

SVREW vs GKOSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SVREW
GKOS
StockJun 22May 26Return
SaverOne 2014 Ltd (SVREW)1003.3-96.7%
Glaukos Corporation (GKOS)100295.4+195.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: SVREW vs GKOS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GKOS leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. SaverOne 2014 Ltd is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SVREW
SaverOne 2014 Ltd
The Income Pick

SVREW is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • beta 0.58
  • Lower volatility, beta 0.58, Low D/E 69.7%, current ratio 1.82x
  • Beta 0.58, current ratio 1.82x
Best for: income & stability and sleep-well-at-night
GKOS
Glaukos Corporation
The Growth Play

GKOS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 32.3%, EPS growth -18.4%, 3Y rev CAGR 21.5%
  • 457.1% 10Y total return vs SVREW's -97.1%
  • 32.3% revenue growth vs SVREW's -38.1%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthGKOS logoGKOS32.3% revenue growth vs SVREW's -38.1%
Quality / MarginsGKOS logoGKOS-34.3% margin vs SVREW's -18.8%
Stability / SafetySVREW logoSVREWBeta 0.58 vs GKOS's 1.20
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)GKOS logoGKOS+52.0% vs SVREW's -41.9%
Efficiency (ROA)GKOS logoGKOS-20.1% ROA vs SVREW's -95.4%, ROIC -9.2% vs -7.5%

SVREW vs GKOS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SVREWSaverOne 2014 Ltd

Segment breakdown not available.

GKOSGlaukos Corporation
FY 2019
Glaucoma
97.5%$231M
Corneal Health
2.5%$6M

SVREW vs GKOS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGKOSLAGGINGSVREW

Income & Cash Flow (Last 12 Months)

GKOS leads this category, winning 4 of 6 comparable metrics.

GKOS is the larger business by revenue, generating $551M annually — 442.1x SVREW's $1M. Profitability is closely matched — net margins range from -34.3% (GKOS) to -18.8% (SVREW). On growth, SVREW holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSVREW logoSVREWSaverOne 2014 LtdGKOS logoGKOSGlaukos Corporati…
RevenueTrailing 12 months$1M$551M
EBITDAEarnings before interest/tax-$23M-$40M
Net IncomeAfter-tax profit-$23M-$189M
Free Cash FlowCash after capex-$23M-$18M
Gross MarginGross profit ÷ Revenue+4.3%+78.1%
Operating MarginEBIT ÷ Revenue-18.8%-15.6%
Net MarginNet income ÷ Revenue-18.8%-34.3%
FCF MarginFCF ÷ Revenue-18.5%-3.4%
Rev. Growth (YoY)Latest quarter vs prior year+2.5%+41.2%
EPS Growth (YoY)Latest quarter vs prior year+85.7%-6.3%
GKOS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Insufficient data to determine a leader in this category.
MetricSVREW logoSVREWSaverOne 2014 LtdGKOS logoGKOSGlaukos Corporati…
Market CapShares × price$7.9B
Enterprise ValueMkt cap + debt − cash$7.9B
Trailing P/EPrice ÷ TTM EPS-40.90x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue15.47x
Price / BookPrice ÷ Book value/share11.69x
Price / FCFMarket cap ÷ FCF
Insufficient data to determine a leader in this category.

Profitability & Efficiency

GKOS leads this category, winning 5 of 9 comparable metrics.

GKOS delivers a -26.5% return on equity — every $100 of shareholder capital generates $-26 in annual profit, vs $-139 for SVREW. GKOS carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to SVREW's 0.70x. On the Piotroski fundamental quality scale (0–9), SVREW scores 5/9 vs GKOS's 3/9, reflecting solid financial health.

MetricSVREW logoSVREWSaverOne 2014 LtdGKOS logoGKOSGlaukos Corporati…
ROE (TTM)Return on equity-139.1%-26.5%
ROA (TTM)Return on assets-95.4%-20.1%
ROICReturn on invested capital-7.5%-9.2%
ROCEReturn on capital employed-2.8%-10.3%
Piotroski ScoreFundamental quality 0–953
Debt / EquityFinancial leverage0.70x0.21x
Net DebtTotal debt minus cash-$6M$49M
Cash & Equiv.Liquid assets$13M$91M
Total DebtShort + long-term debt$7M$140M
Interest CoverageEBIT ÷ Interest expense-7.79x-18.69x
GKOS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GKOS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in GKOS five years ago would be worth $16,155 today (with dividends reinvested), compared to $288 for SVREW. Over the past 12 months, GKOS leads with a +52.0% total return vs SVREW's -41.9%. The 3-year compound annual growth rate (CAGR) favors GKOS at 31.7% vs SVREW's -64.2% — a key indicator of consistent wealth creation.

MetricSVREW logoSVREWSaverOne 2014 LtdGKOS logoGKOSGlaukos Corporati…
YTD ReturnYear-to-date-32.0%+21.2%
1-Year ReturnPast 12 months-41.9%+52.0%
3-Year ReturnCumulative with dividends-95.4%+128.7%
5-Year ReturnCumulative with dividends-97.1%+61.5%
10-Year ReturnCumulative with dividends-97.1%+457.1%
CAGR (3Y)Annualised 3-year return-64.2%+31.7%
GKOS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SVREW and GKOS each lead in 1 of 2 comparable metrics.

SVREW is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than GKOS's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GKOS currently trades 91.4% from its 52-week high vs SVREW's 19.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSVREW logoSVREWSaverOne 2014 LtdGKOS logoGKOSGlaukos Corporati…
Beta (5Y)Sensitivity to S&P 5000.58x1.20x
52-Week HighHighest price in past year$0.06$146.75
52-Week LowLowest price in past year$0.01$73.16
% of 52W HighCurrent price vs 52-week peak+19.5%+91.4%
RSI (14)Momentum oscillator 0–10057.363.0
Avg Volume (50D)Average daily shares traded10K678K
Evenly matched — SVREW and GKOS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricSVREW logoSVREWSaverOne 2014 LtdGKOS logoGKOSGlaukos Corporati…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$146.67
# AnalystsCovering analysts24
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

GKOS leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.

Best OverallGlaukos Corporation (GKOS)Leads 3 of 6 categories
Loading custom metrics...

SVREW vs GKOS: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is SVREW or GKOS a better buy right now?

For growth investors, Glaukos Corporation (GKOS) is the stronger pick with 32.

3% revenue growth year-over-year, versus -38. 1% for SaverOne 2014 Ltd (SVREW). Analysts rate Glaukos Corporation (GKOS) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SVREW or GKOS?

Over the past 5 years, Glaukos Corporation (GKOS) delivered a total return of +61.

5%, compared to -97. 1% for SaverOne 2014 Ltd (SVREW). Over 10 years, the gap is even starker: GKOS returned +457. 1% versus SVREW's -97. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SVREW or GKOS?

By beta (market sensitivity over 5 years), SaverOne 2014 Ltd (SVREW) is the lower-risk stock at 0.

58β versus Glaukos Corporation's 1. 20β — meaning GKOS is approximately 107% more volatile than SVREW relative to the S&P 500. On balance sheet safety, Glaukos Corporation (GKOS) carries a lower debt/equity ratio of 21% versus 70% for SaverOne 2014 Ltd — giving it more financial flexibility in a downturn.

04

Which is growing faster — SVREW or GKOS?

By revenue growth (latest reported year), Glaukos Corporation (GKOS) is pulling ahead at 32.

3% versus -38. 1% for SaverOne 2014 Ltd (SVREW). Over a 3-year CAGR, SVREW leads at 55. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SVREW or GKOS?

Glaukos Corporation (GKOS) is the more profitable company, earning -37.

0% net margin versus -20. 8% for SaverOne 2014 Ltd — meaning it keeps -37. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GKOS leads at -17. 1% versus -1975. 8% for SVREW. At the gross margin level — before operating expenses — GKOS leads at 77. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — SVREW or GKOS?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is SVREW or GKOS better for a retirement portfolio?

For long-horizon retirement investors, SaverOne 2014 Ltd (SVREW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

58)). Both have compounded well over 10 years (SVREW: -97. 1%, GKOS: +457. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between SVREW and GKOS?

These companies operate in different sectors (SVREW (Technology) and GKOS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SVREW is a small-cap quality compounder stock; GKOS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SVREW

High-Growth Disruptor

  • Sector: Technology
  • Revenue Growth > 124%
Run This Screen
Stocks Like

GKOS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Gross Margin > 46%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SVREW and GKOS on the metrics below

Revenue Growth>
%
(SVREW: 249.8% · GKOS: 41.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.